Cite
HARVARD Citation
Metze, C. et al. (2019). Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies. CNS neuroscience & therapeutics. pp. 245-254. [Online].